LAVAL, Quebec, Sept. 16, 2020 /PRNewswire/ -- Bausch Health
Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company")
today announced it has published a presentation that Joseph C. Papa, chairman and CEO, and
Paul S. Herendeen, executive vice
president and chief financial officer, are scheduled to present at
the virtual 18th Annual Morgan Stanley Global Healthcare
Conference today, Sept. 16, 2020, at
1:15 p.m. ET.
The presentation provides an update on Bausch Health's current
business recovery in the wake of the COVID-19 pandemic, as well as
an update and progress report regarding the Company's previously
disclosed intention to spin off its eye health business.
The presentation is available on the Investor Relations page of
the Bausch Health Companies Inc. web site at:
http://ir.bauschhealth.com/events-and-presentations/2020. A live
webcast and audio archive of the event will be also be available
for 90 days.
About Bausch Health
Bausch Health Companies Inc.
(NYSE/TSX: BHC) is a global company whose mission is to improve
people's lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device
and over-the-counter products, primarily in the therapeutic areas
of eye health, gastroenterology and dermatology. We are delivering
on our commitments as we build an innovative company dedicated to
advancing global health. More information can be found at
www.bauschhealth.com.
Forward-looking Statements
This news release may
contain forward-looking statements, which may generally be
identified by the use of the words
"anticipates," "expects," "intends," "plans," "should," "could," "would," "may,"
"believes," "estimates," "potential," "target," or "continue" and
variations or similar expressions. These statements are based upon
the current expectations and beliefs of management and are subject
to certain risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements. These risks and uncertainties include, but are not
limited to, the risks and uncertainties discussed in the Bausch
Health's most recent annual report on Form 10-K and detailed from
time to time in Bausch Health's other filings with the U.S.
Securities and Exchange Commission and the Canadian Securities
Administrators, which factors are incorporated herein by reference.
They also include, but are not limited to, risks and uncertainties
caused by or relating to the evolving COVID-19 pandemic, and the
fear of that pandemic and its potential effects, the severity,
duration and future impact of which are highly uncertain and cannot
be predicted, and which may have a material adverse impact on
Bausch Health, including but not limited to its project development
timelines, and costs (which may increase), risks and uncertainties
relating to the Company's proposed plan to spin off its eye health
business, including the expected benefits and costs of the spinoff
transaction, the expected timing of completion of the spinoff
transaction and its terms. Readers are cautioned not to place
undue reliance on any of these forward-looking statements. These
forward-looking statements speak only as of the date hereof. Bausch
Health undertakes no obligation to update any of these
forward-looking statements to reflect events or circumstances after
the date of this news release or to reflect actual outcomes, unless
required by law.
Investor
Contact:
|
Media
Contact:
|
Arthur
Shannon
|
Lainie
Keller
|
arthur.shannon@bauschhealth.com
|
lainie.keller@bauschhealth.com
|
(514)
856-3855
|
(908)
927-1198
|
(877) 281-6642 (toll
free)
|
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bausch-health-provides-company-update-at-18th-annual-morgan-stanley-global-healthcare-conference-301132165.html
SOURCE Bausch Health Companies Inc.